SigPath™ ERK Phosphorylation Assay Kit

CAT#: ITS-1125-WB20
Product Type: Assay Kit
Species: Human, mouse, rat
Target: Phosphorylated ERK1 (T202/Y204) and ERK2 (T185/Y187) within intact, fixed cellular environments.
Brand: SigPath
Development Stage: Research-Grade Signal Pathway Assay Development
Short Description
Quantifies ERK1/2 phosphorylation levels in whole cells using an ELISA-based colorimetric method.
Brand
SigPath
Development Stage
Research-Grade Signal Pathway Assay Development
Description
The SigPath™ ERK Phosphorylation Assay Kit offers a streamlined, cell-based ELISA for quantifying ERK1/2 phosphorylation without the need for cell lysate preparation. This high-throughput system normalizes phosphorylation levels to total cellular protein, ensuring exceptional accuracy for screening kinase inhibitors and studying MAPK signaling. By reducing assay time to just 6.5 hours, it provides a rapid and robust tool for drug discovery and signal transduction research in pre-clinical studies.
Features
Dual-Signal Precision: Measures phosphorylated ERK and total protein concurrently in the same well to ensure robust, normalized data accuracy.
Streamlined Workflow: Eliminates time-consuming cell lysis and protein transfer steps, reducing total assay time to approximately 6.5 hours.
High-Throughput Compatibility: Optimized for 96-well formats, facilitating rapid screening of thousands of compounds with automated liquid handling systems.
Sensitive Fluorescence Detection: Utilizes high-performance immunoenzymatic labeling to detect subtle shifts in phosphorylation status across human, mouse, and rat species.
Process Relevance
Monitoring ERK activation levels to support high-throughput inhibitor screening and precise signal transduction pathway optimization during lead validation.
Application Stage
Target validation, secondary lead optimization, and high-throughput drug screening within the pharmaceutical research and development pipeline.
Applications
Designed for quantitative fluorescence immunoenzymatic determination of ERK1/2 phosphorylation in cultured cells to evaluate ligand efficacy, kinase inhibitor potency, and growth factor-induced signaling.
Qualified With
Internal performance validation using reference standards under defined assay conditions.
Target
Phosphorylated ERK1 (T202/Y204) and ERK2 (T185/Y187) within intact, fixed cellular environments.
Detection Method
Fluorescence Detection (Ex 530 nm / Em 585 nm or Ex 360 nm / Em 451 nm)
Sample Type
Cells
Research Areas
Oncology therapeutics, cellular differentiation, drug discovery, immunology, signal transduction, etc.
Size
100 tests
Data Output Type
Quantitative fluorescence-based phosphorylation measurement normalized to total cellular protein content using dual-wavelength endpoint detection.
Assay Time
6.5 h
Species
Human, mouse, rat
Storage
Store at −20 °C; upon receipt to maintain reagent stability. Follow recommended handling procedures to ensure consistent assay performance.
Storage Comment
Avoid repeated freeze-thaw cycles. During use, minimize the time components are exposed to room temperature and return them promptly to −20 ℃ storage after handling. Do not store at elevated temperatures for extended periods.
Expiry Date
6 months under recommended storage conditions to ensure optimal performance.
Note
For bulk pricing or custom reagent inquiries, please contact us by email or phone. Products are shipped on ice via FedEx.
Restrictions
For Research Use Only (RUO). Not intended for diagnostic or therapeutic use.
Shipping
Shipped on ice under temperature-controlled conditions.
Background
The ERK1/2 cascade is a critical mediator of extracellular stimuli, governing essential processes like proliferation and survival. Its dysregulation is a hallmark of many cancers, making it a primary therapeutic target.
Pathways
Acting downstream of Ras and Raf, activated MEK1/2 phosphorylates ERK1/2. Once activated, ERK translocates to the nucleus to regulate transcription factors, driving cell cycle progression.
For Research Use Only | Not For Clinical Use
Online Inquiry